Shionogi Healthcare, Shionogi, and Pixie Dust Technologies Enter a Business Partnership Agreement to Launch Business Involving Brain Activation through Sound Stimulation
<From the left of the photo>
Hiroyuki Kobayashi, Vice President of New Business Promotion Department, Shionogi & Co.
Satoru Yoshimoto, President of Shionogi Healthcare & Co.
Taiichiro Murakami, Representative Director of Pixie Dust Technologies, Inc.
Yousuke Miharu, Corporate Officer, Senior Vice President of Integrated Disease Care Division, Shionogi & Co.
■About "Brain Activation and Improvement of Cognitive Function through Sound Stimulation"
■Comments from Yousuke Miharu, Corporate Officer, Senior Vice President of Integrated Disease Care Division, Shionogi & Co.
■Comments from Satoru Yoshimoto, President of Shionogi Healthcare & Co.
■Comments from Taiichiro Murakami, Representative Director of Pixie Dust Technologies, Inc.
With the conclusion of this business partnership agreement, the three companies will deploy their respective expertise to further expand the possibilities of this business.
1. Sonic technology that may enhance cerebral gamma wave rhythmic activity.
2. Herrmann, C. S., & Demiralp, T. (2005). Human EEG gamma oscillations in neuropsychiatric disorders. Clinical neurophysiology, 116(12), 2719-2733.
3. Shionogi Press release on June 21,2022
Conclusion of a basic agreement between Pixie Dust Technologies and Shionogi for joint research for improvement of cognitive function and brain activation by sound stimulation
4. Annual Report on the Aging Society 2022
This announcement contains forward-looking statements. These statements are based on expectations in light of the information currently available, assumptions that are subject to risks and uncertainties which could cause actual results to differ materially from these statements. Risks and uncertainties include general domestic and international economic conditions such as general industry and market conditions, and changes of interest rate and currency exchange rate. These risks and uncertainties particularly apply with respect to product-related forward-looking statements. Product risks and uncertainties include, but are not limited to, completion and discontinuation of clinical trials; obtaining regulatory approvals; claims and concerns about product safety and efficacy; technological advances; adverse outcome of important litigation; domestic and foreign healthcare reforms and changes of laws and regulations. Also for existing products, there are manufacturing and marketing risks, which include, but are not limited to, inability to build production capacity to meet demand, lack of availability of raw materials and entry of competitive products. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
■About Shionogi & Co., Ltd.
Shionogi has identified “improving social productivity” as one of the material issue (materiality) we should address. We will continue to strive to deliver innovative treatments for cognitive function disorders with high unmet medical needs and to thereby contribute to improving the quality of life and productivity of people suffering from mental / neurological disease and those who support them.
For more information, please visit https://www.shionogi.com/global/en/
■About Shionogi Healthcare & Co., Ltd.
The Shionogi Group has been improving people’s health ever since its foundation more than 140 years ago. As part of that, Shionogi Healthcare was established in January 2016 with a philosophy of "always providing the best healthcare value necessary to protect people's health." We will enhance the competitiveness of our healthcare business by adding value through multi-layered operations and alliances, and contribute to the extension of healthy life expectancy through superior products, information, and services.
■About Pixie Dust Technologies, Inc.
PxDT, whose slogan is “Digitally Rebalanced,” is university startup that aims to be a driving force in leading us to a new equilibrium point by looking at the world from the perspective of digital technology. We will research and develop interface technologies that connect the digital and physical worlds, and contribute to their practical application by seamlessly incorporating them into society
For Further Information, Contact:
SHIONOGI Website Inquiry Form : https://www.shionogi.com/global/en/contact.html
Pixie Dust Technologies Website Inquiry Form : https://pixiedusttech.com/contact/
Shionogi Healthcare Contact information : E-mail adress email@example.com